---
title: KCAS Bio vs Sword Bio
slug_a: kcasbio
slug_b: swordbio
site: cro
review_signal_gate: closed
canonical_path: /compare/kcasbio/swordbio
---

# KCAS Bio vs Sword Bio

Side-by-side profile data from each company listing on this directory.

## KCAS Bio

- Profile: [/companies/kcasbio](/companies/kcasbio)

KCAS Bio — Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities.

Services: 14. Modalities: 5. Indications: 12. Locations: 7. Certifications: 0. The strongest documented coverage currently appears in services (14).

### Services

- Discovery Research
- In Vivo PK / PD Studies
- GLP Toxicology
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Central Laboratory Services
- Translational Research
- Microbiology Services
- Virology Services
- Immunology & Inflammation Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Dermatology
- Ophthalmology
- Gastroenterology
- Nephrology

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Discovery
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Sword Bio

- Profile: [/companies/swordbio](/companies/swordbio)

Sword Bio — Bioanalytical CRO offering ligand binding assay development, PK, immunogenicity (ADA and NAb), and custom biomarker assays under non-GLP, spirit-of-GLP, and GLP conditions. Supports clients from discovery through clinical Phase IV.

Services: 5. Modalities: 4. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Bioanalysis
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Analytical Method Development & Validation

### Modalities

- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
- Gene Therapy

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Data not yet provided.